Citable company snapshot
Elevance Health's latest SEC-sourced 2026-06-30 period shows $50.47B in revenue and $1.46B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jun 30, 2026 | $50.47B | $50.18B | +0.6% |
| Operating Income | Jun 30, 2026 | $1.76B | $2.09B | -15.5% |
| Net Income | Jun 30, 2026 | $1.46B | $1.76B | -17.1% |
| Operating Cash Flow (computed) | Jun 30, 2026 | $1.91B | $4.33B | -55.8% |
| Free Cash Flow (computed) | Jun 30, 2026 | $1.63B | $4.10B | -60.3% |
Source: SEC EDGAR financial statements; period Jun 30, 2026; filed Jul 15, 2026; accession 0001156039-26-000060.
ELV company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.